Axa Stock Based Compensation To Revenue from 2010 to 2025

EQH Stock  USD 53.50  0.25  0.47%   
Axa Equitable's Stock Based Compensation To Revenue is decreasing with slightly volatile movements from year to year. Stock Based Compensation To Revenue is estimated to finish at -0.01 this year. Stock Based Compensation To Revenue is a metric that compares the total value of stock-based compensation granted by Axa Equitable Holdings to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. View All Fundamentals
 
Stock Based Compensation To Revenue  
First Reported
2010-12-31
Previous Quarter
(0.02)
Current Value
(0.01)
Quarterly Volatility
0.01379144
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Axa Equitable financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axa Equitable's main balance sheet or income statement drivers, such as Depreciation And Amortization of 545.7 M, Interest Expense of 175.3 M or Selling General Administrative of 2.4 B, as well as many indicators such as Price To Sales Ratio of 0.81, Ptb Ratio of 4.16 or Book Value Per Share of 28.85. Axa financial statements analysis is a perfect complement when working with Axa Equitable Valuation or Volatility modules.
  
Check out the analysis of Axa Equitable Correlation against competitors.

Latest Axa Equitable's Stock Based Compensation To Revenue Growth Pattern

Below is the plot of the Stock Based Compensation To Revenue of Axa Equitable Holdings over the last few years. It is a metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. Axa Equitable's Stock Based Compensation To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axa Equitable's overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation To Revenue10 Years Trend
Slightly volatile
   Stock Based Compensation To Revenue   
       Timeline  

Axa Stock Based Compensation To Revenue Regression Statistics

Arithmetic Mean0.01
Coefficient Of Variation113.45
Mean Deviation0.01
Median0.02
Standard Deviation0.01
Sample Variance0.0002
Range0.0447
R-Value(0.55)
Mean Square Error0.0001
R-Squared0.30
Significance0.03
Slope(0)
Total Sum of Squares0

Axa Stock Based Compensation To Revenue History

2025 -0.0149
2024 -0.0157
2023 -0.0137
2022 0.0226
2021 0.0205
2020 0.0169
2019 0.029

About Axa Equitable Financial Statements

Investors use fundamental indicators, such as Axa Equitable's Stock Based Compensation To Revenue, to determine how well the company is positioned to perform in the future. Although Axa Equitable's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Stock Based Compensation To Revenue(0.02)(0.01)

Currently Active Assets on Macroaxis

When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:
Check out the analysis of Axa Equitable Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Dividend Share
0.22
Earnings Share
(0.91)
Revenue Per Share
32.942
Quarterly Revenue Growth
(0.25)
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.